Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-015320
Filing Date
2021-04-07
Accepted
2021-04-07 18:23:48
Documents
1
Period of Report
2021-04-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 16968
  Complete submission text file 0000899243-21-015320.txt   18315
Mailing Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address
Svennilson Peter (Reporting) CIK: 0001606074 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39219 | Film No.: 21813320

Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Issuer) CIK: 0001628171 (see all company filings)

EIN.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)